Dynavax Technologies
DVAX
#5481
Rank
S$1.67 B
Marketcap
S$14.23
Share price
0.23%
Change (1 day)
-17.82%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.36 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is S$0.36 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$0.34 B1.92%
2023-12-31S$0.33 B-1.9%
2022-12-31S$0.34 B-0.6%
2021-12-31S$0.34 B20.74%
2020-12-31S$0.28 B-1.24%
2019-12-31S$0.29 B111.75%
2018-12-31S$0.13 B
2014-12-31S$12.63 M
2012-12-31N/A-100%
2011-12-31S$16.58 M9.31%
2010-12-31S$15.17 M-12.69%
2009-12-31S$17.38 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
S$59.3 M-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$8.53 B 2,212.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$53.60 B 14,415.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$32.31 B 8,650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$42.27 B 11,348.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
S$30.91 B 8,271.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$78.83 B 21,248.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$22.12 B 5,890.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
S$70.72 B 19,051.72%๐Ÿ‡บ๐Ÿ‡ธ USA